Lonza Licenses Gene Expression to Kyowa Hakko


Lonza and Kyowa Hakko Kogyo Co., Ltd. have signed an agreement  where Lonza will license its GS Gene Expression System (GS: glutamine synthetase) to Kyowa Hakko and its US subsidiary BioWa Inc. (Kyowa Hakko Group). Prior to this agreement BioWa and Lonza entered into a strategic research collaboration agreement combining Kyowa Hakko’s POTELLIGENT technology with Lonza’s GS Gene Expression System.

This worldwide, non-exclusive umbrella research and license agreement enables Kyowa Hakko Group to use Lonza’s proprietary GS-System and the POTELLIGENT technology as a platform for the production of antibodies and recombinant proteins being developed by Kyowa Hakko Group. For more information, visit www.lonza.com.

More in Companies